Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy. It offers BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns. In addition, Polynovo Limited licensed its NovoSorb to Smith & Nephew for orthopaedic applications. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone61 3 8681 4050
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$8.66 million
Profitability
Miscellaneous
Employees41
Next Earnings DateN/A
OptionableNot Optionable
Polynovo (ASX:PNV) Frequently Asked Questions
What is Polynovo's stock symbol?
Polynovo trades on the ASX under the ticker symbol "PNV."
Has Polynovo been receiving favorable news coverage?
Press coverage about PNV stock has been trending positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Polynovo earned a coverage optimism score of 2.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the stock's share price in the next few days. View News Stories for Polynovo.
Who are some of Polynovo's key competitors?
Some companies that are related to Polynovo include BTG (BTG), MorphoSys (MOR), MorphoSys (MOR), Abcam (ABC), Genus (GNS), Clinuvel Pharmaceuticals (CUV), Concordia International (CXR), Mesoblast (MSB), Resverlogix (RVX), Oxford BioMedica (OXB), Kodiak Sciences (KOD), Starpharma (SPL), Neptune Wellness Solutions (NEPT), BELLUS Health (BLU) and Theratechnologies (TH).
Who are Polynovo's key executives?
Polynovo's management team includes the folowing people:
- Mr. Paul Brennan, Chief Exec. Officer
- Mr. Greg Lewis M.A.I.C.D., M.B.A., Chief Operating Officer
- Mr. Jan-Marcel Gielen, CFO & Company Sec.
- Dr. Tim Moore, Principal Scientist
- Mr. David Smith, Manufacturing Mang.
What is Polynovo's stock price today?
One share of PNV stock can currently be purchased for approximately A$1.58.
How big of a company is Polynovo?
What is Polynovo's official website?
How can I contact Polynovo?
The company can be reached via phone at 61 3 8681 4050.
MarketBeat Community Rating for Polynovo (ASX PNV)
MarketBeat's community ratings are surveys of what our community members think about Polynovo and other stocks. Vote "Outperform" if you believe PNV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PNV will underperform the S&P 500 over the long term. You may vote once every thirty days.
